openPR Logo
Press release

Worldwide Injectable Drug Delivery Devices Market 2018; Size, Statistics, Revenue and Trends; Forecast with Treatments and Major Key Vendors Antares Pharma, AstraZeneca, Becton, Dickinson and Company, Eli Lilly and Company, F.Hoffmann-La Roche AG, Johnson

01-22-2019 11:34 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Market Research Future

Injectable Drug Delivery Devices Market

Injectable Drug Delivery Devices Market

Market scenario:

Injectable drug delivery devices include an array of medical devices ranging from conventional syringes, needle-free injectors to auto and pen injectors. The demand for such devices has witnessed a rise in recent years on account of the mounting prevalence of chronic diseases across the globe. Market Research Future (MRFR) predicts the growth of the global injectable drug delivery devices market to be splendid at a CAGR of 11.5% over the forecast period of 2018-2023. The global injectable drug delivery devices market is likely to surpass a valuation of USD 31,900 Mn by the end of 2023.

Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/1211

The growth of the global injectable drug delivery devices market is sustained by the high prevalence of chronic diseases such as diabetes and cancer. Injectable drug delivery devices are used in the treatment of such medical conditions which spurs the demand for injectable drug delivery devices. In addition, owing to their use of use, injectable drug delivery devices are being progressively adopted. Other contributing factors to the growth of the market include key developments within the market as a result of R&D and clinical trials. Additionally, the rise in a number of FDA approvals also boosts the growth of the market. Introduction of advanced injectable drug delivery devices with superior functional capabilities is anticipated to reflect positively on the market growth.

Conversely, the growth of the global injectable drug delivery devices market might be restricted by the underlying risk of cross-contamination. Nevertheless, the proliferation of vaccination programs across underdeveloped countries provides lucrative growth opportunities for market expansion.

Segmentation

The global injectable drug delivery devices market has been segmented based on device, therapeutic application, usage pattern, site of delivery, distribution channel, and facility of use.

By device, the global injectable drug delivery device market has been segmented into conventional injection devices and self-injection devices. The conventional injection devices segment has been further segmented into material, product, and utility. The self-injectable devices segment has been further segmented into needle-free injectors and pen systems and auto-injectors. The conventional injection devices segment commands the largest share of the global market.

By therapeutic application, the global injectable drug delivery device market has been segmented into autoimmune diseases, hormonal disorders, cancer, and others. The autoimmune diseases segment is the largest segment by therapeutic application.

By usage pattern, the global injectable drug delivery devices market has been segmented into curative and immunization. The curative segment is expected to be the fastest growing segment over the forecast period.

By site of delivery, the global injectable drug delivery devices market has been segmented into intramuscular, subcutaneous, and intradermal. The intramuscular segment is the largest segment.

By distribution channel, the global injectable drug delivery devices market has been segmented into hospital & retail pharmacies and online platforms. The hospitals & retail pharmacies segment is the largest segment while the online platform segment is expected to be the fastest growing segment by the end of 2023.

By facility of use, the global injectable drug delivery devices market has been segmented into hospitals and clinics, home care settings, and others.

Regional Analysis

By region, the global injectable drug delivery devices market has been segmented into the Americas, Asia Pacific (APAC), Europe, and the Middle East and Africa (MEA).

The Americas is leading the global injectable drug delivery devices market. Expansion of the biotechnology industry, the surging prevalence of chronic diseases and a robust healthcare sector spur the growth of the market. Also, the region is a frontrunner in the incorporation of technologically advanced healthcare solutions which further accelerates the growth of the market.

Europe held the second largest share of the global market in 2017 and is likely to reach USD 13,074.3 Mn by the end of 2023. High adoption of advanced healthcare services coupled with extensive R&D efforts can be credited for the growth of the Europe market.

APAC market for injectable drug delivery devices market is expected to register the highest CAGR of 11.45 OVER TEH FORECAST period. High demand for advanced healthcare in rapidly growing economies drives the APAC market.

Lack of awareness and less exposure to primary healthcare services in the underdeveloped regions of the Middle East & Africa is expected to impede the growth of the market.

Competitive Landscape

The key players in the global injectable drug delivery devices market include Eli Lilly and Company, Antares Pharma, Inovio Pharmaceuticals Inc., Eisai Co. Ltd., Becton, Sanofi, Johnson & Johnson Services Inc., Novo Nordisk, AstraZeneca, F.Hoffmann-La Roche AG, Teva Pharmaceutical Industries Ltd., Pfizer Inc., Dickinson and Company, Novartis AG, and Mylan N.V.

Browse Complete 80 Pages Premium Research Report Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/injectable-drug-delivery-devices-market-1211

About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Worldwide Injectable Drug Delivery Devices Market 2018; Size, Statistics, Revenue and Trends; Forecast with Treatments and Major Key Vendors Antares Pharma, AstraZeneca, Becton, Dickinson and Company, Eli Lilly and Company, F.Hoffmann-La Roche AG, Johnson here

News-ID: 1520801 • Views:

More Releases from Market Research Future

Generative AI in Fintech Market to Grow at a CAGR of 24.5% by 2032
Generative AI in Fintech Market to Grow at a CAGR of 24.5% by 2032
Generative AI in Fintech Market Overview: Generative AI has been making significant strides in the FinTech market, offering a wide range of applications and opportunities for growth. Market Size and Growth: The generative AI in fintech Market is projected to grow from USD 1,111.0 million in 2023 to USD 7,984.6 million by 2032, exhibiting a compound annual growth rate (CAGR) of 24.5% during the forecast period (2023 - 2032). Indicating exponential growth and
Pharmaceutical Packaging Market Size, Share Growth Status, Emerging Technology, Key Players, Industry Challenges, and Forecast till 2032
Pharmaceutical Packaging Market Size, Share Growth Status, Emerging Technology, …
In the ever-evolving landscape of the pharmaceutical industry, packaging plays a pivotal role in ensuring the safety, efficacy, and integrity of medical products. The pharmaceutical packaging market is witnessing dynamic growth driven by technological advancements, stringent regulatory requirements, and increasing demand for personalized medicine and biologics. With a focus on patient safety, convenience, and sustainability, the market is undergoing transformative changes, fostering innovation and creativity among industry players. Pharmaceutical Packaging Market
US Color Cosmetics Market Report Presents an Overall Analysis, Development Trends, Driving Forces, Opportunities
US Color Cosmetics Market Report Presents an Overall Analysis, Development Trend …
Color cosmetics have long been an integral part of American culture, offering a wide range of products to enhance beauty and express individuality. The US color cosmetics market is a dynamic and vibrant landscape, driven by evolving consumer preferences, innovative product offerings, and changing beauty trends. In this article, we explore the key drivers, trends, restraints, and opportunities shaping the US color cosmetics market. The US Color Cosmetics Market was valued
US Takeout Containers Market Key Players, End User Demand and Analysis Growth Trends by 2032
US Takeout Containers Market Key Players, End User Demand and Analysis Growth Tr …
Takeout containers have become an integral part of the modern dining experience, offering convenience and portability for consumers on-the-go. In the United States, the takeout containers market has witnessed significant growth in recent years, driven by changing consumer lifestyles, the rise of food delivery services, and increasing environmental concerns. This article explores the key trends, drivers, restraints, and opportunities shaping the US takeout containers market. US Takeout Containers Market size was

All 5 Releases


More Releases for Injectable

Injectable Sumatriptan Market 2021 | Detailed Report
ReportsnReports publishes the report titled Injectable Sumatriptan that presents a 360-degree overview of the market under one roof. The report is developed with the meticulous efforts of an enthusiastic and experienced team of experts, analyts, and researchers that makes the report a valuable asset for stakeholders to make robust decisions. This report also provides an in-depth overview of product type, specification, technology, and production analysis considering vital factors like cost,
Small-Molecule Injectable Market
The global Small-Molecule Injectable Market was valued at US$ 55.8 Bn in 2020. Expanding at a 7.3% CAGR, the market valuation is expected to top US$ 112.9 Bn by 2031, finds ESOMAR-certified consulting firm Future Market Insights (FMI) in a recent market analysis. The COVID-19 pandemic outbreak has sparked efforts to repurpose already-approved medicines for treatment. Several clinical studies are now being conducted on different antiviral medicines and small-molecule injectables that
Global Injectable Drug Delivery Devices Market | Global Injectable Drug Delivery …
The injectable drug delivery devices market involves of sales of conventional syringes, needle-free injectors, auto injectors and pen injectors. The market contains the sales of the Injectable devices that have been comprehensively utilized for several routes of drug administration, such as intravenous, subcutaneous, intradermal, intra-peritoneal, and intra-muscular and several others to cure the medical conditions vacillating from cancer to autoimmune disorders. The injectable drug delivery devices utilized in hospitals, clinics
Global Injectable Drug Delivery Market to 2028 |Retail Pharmacies, Injectable Dr …
Market Research Hub (MRH) has carefully analyzed this research study titled Injectable Drug Delivery Market: Self-injectors to Remain Fastest Growing Product Type During the Forecast Period: Global Industry Analysis 2013-2017 and Opportunity Assessment 2018-2028, which is available on its online portal. The aim of this assessment is to highlight the various projections expected to occur in the global market for Injectable Drug Delivery. Readers can gain knowledge related to prime
Ioversol Market Report 2018: Segmentation by Type (Ioversol 34% Injectable Solut …
Global Ioversol market research report provides company profile for China Resources Pharmaceutical (Shanghai) Co, HB Ocean, Novalek Pharmaceuticals Pvt. Ltd, Stellence Pharmscience Pvt. Ltd, A.S. Joshi & Company, Liebel-Flarsheim Company LLC, Guerbet, Jiangsu Hengrui Medicine Co, Mallinckrodt Pharmaceuticals, Ultraject and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of
Injectable Targeted Therapy Market: Primary application of injectable targeted t …
Targeted delivery is a clinical treatment used to deliver medication in patients to increase the concentration of medication in some parts of the body. Target specific drug delivery is localized, prolonged, targeted and have protected drug interaction with the diseased tissue. The advantage of injectable targeted therapy was the decrease in frequency of the dosages that are delivered to the patient, it more uniform effect of the drug, reduction of